2014 Q4 Form 10-Q Financial Statement

#000119312514403325 Filed on November 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $55.36M $44.33M $92.67M
YoY Change -15.27% -52.17% 30.49%
Cost Of Revenue $42.90M $33.84M $72.29M
YoY Change -19.51% -53.18% 28.24%
Gross Profit $12.51M $10.49M $20.38M
YoY Change 3.88% -48.56% 39.17%
Gross Profit Margin 22.59% 23.65% 21.99%
Selling, General & Admin $6.500M $6.171M $10.26M
YoY Change -34.34% -39.84% -7.53%
% of Gross Profit 51.98% 58.85% 50.32%
Research & Development $10.20M $7.006M $12.44M
YoY Change 13.33% -43.67% -15.36%
% of Gross Profit 81.56% 66.81% 61.02%
Depreciation & Amortization $1.520M $1.850M $2.230M
YoY Change -30.28% -17.04% -19.78%
% of Gross Profit 12.15% 17.64% 10.94%
Operating Expenses $16.70M $14.38M $25.25M
YoY Change -12.57% -43.03% -45.7%
Operating Profit -$4.194M -$3.896M -$4.864M
YoY Change -40.6% -19.9% -84.73%
Interest Expense -$100.0K -$63.00K $31.00K
YoY Change -303.23% -56.94%
% of Operating Profit
Other Income/Expense, Net $1.500M -$61.00K $59.00K
YoY Change -1600.0% -203.39% -231.11%
Pretax Income -$4.000M -$8.808M -$4.774M
YoY Change -81.48% 84.5% -85.0%
Income Tax $100.0K $24.00K $319.0K
% Of Pretax Income
Net Earnings -$4.446M -$8.832M -$5.093M
YoY Change -79.13% 73.41% -84.05%
Net Earnings / Revenue -8.03% -19.92% -5.5%
Basic Earnings Per Share -$0.10 -$0.23
Diluted Earnings Per Share -$0.13 -$0.23 -$149.6K
COMMON SHARES
Basic Shares Outstanding 44.64M shares 36.84M shares 34.07M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.90M $25.30M $40.10M
YoY Change -8.21% -36.91% -28.77%
Cash & Equivalents $17.85M $20.16M $18.14M
Short-Term Investments $0.00 $5.100M $22.00M
Other Short-Term Assets $7.900M $4.100M $9.800M
YoY Change -5.95% -58.16% 44.12%
Inventory $37.80M $28.14M $27.03M
Prepaid Expenses
Receivables $24.21M $27.26M $47.54M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $87.78M $84.78M $124.5M
YoY Change -8.21% -31.93% -10.97%
LONG-TERM ASSETS
Property, Plant & Equipment $5.279M $5.778M $11.90M
YoY Change -46.68% -51.42% -20.17%
Goodwill $0.00 $0.00
YoY Change
Intangibles $1.493M $1.527M $2.383M
YoY Change -29.94% -35.92%
Long-Term Investments $0.00 $300.0K $5.300M
YoY Change -100.0% -94.34% -14.52%
Other Assets $467.0K $622.0K $280.0K
YoY Change 29.36% 122.14% -81.33%
Total Long-Term Assets $7.239M $8.269M $19.94M
YoY Change -54.29% -58.54% -22.4%
TOTAL ASSETS
Total Short-Term Assets $87.78M $84.78M $124.5M
Total Long-Term Assets $7.239M $8.269M $19.94M
Total Assets $95.02M $93.05M $144.5M
YoY Change -14.75% -35.61% -12.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $34.54M $29.88M $46.51M
YoY Change 40.76% -35.75% 19.56%
Accrued Expenses $23.84M $20.71M $27.96M
YoY Change 2.46% -25.92% 10.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $2.400M
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $58.38M $50.60M $76.91M
YoY Change 6.73% -34.21% 19.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $932.0K $1.615M $1.932M
YoY Change -49.57% -16.41% -49.16%
Total Long-Term Liabilities $932.0K $1.615M $1.932M
YoY Change -49.57% -16.41% -49.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $58.38M $50.60M $76.91M
Total Long-Term Liabilities $932.0K $1.615M $1.932M
Total Liabilities $64.47M $66.94M $78.84M
YoY Change -3.12% -15.09% 16.11%
SHAREHOLDERS EQUITY
Retained Earnings -$411.2M -$406.7M -$350.2M
YoY Change 10.68% 16.14%
Common Stock $46.00K $44.00K $34.00K
YoY Change 35.29% 29.41%
Preferred Stock
YoY Change
Treasury Stock (at cost) $25.00M $25.00M $25.00M
YoY Change 0.0% 0.0%
Treasury Stock Shares 2.436M shares 2.436M shares 2.436M shares
Shareholders Equity $30.55M $25.16M $65.65M
YoY Change
Total Liabilities & Shareholders Equity $95.02M $93.05M $144.5M
YoY Change -14.75% -35.61% -12.75%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$4.446M -$8.832M -$5.093M
YoY Change -79.13% 73.41% -84.05%
Depreciation, Depletion And Amortization $1.520M $1.850M $2.230M
YoY Change -30.28% -17.04% -19.78%
Cash From Operating Activities -$6.790M -$10.52M -$10.68M
YoY Change -69.76% -1.5% -1850.82%
INVESTING ACTIVITIES
Capital Expenditures -$520.0K -$420.0K -$1.320M
YoY Change -1400.0% -68.18% 206.98%
Acquisitions
YoY Change
Other Investing Activities $5.360M $8.140M $4.630M
YoY Change -25.03% 75.81% 320.91%
Cash From Investing Activities $4.830M $7.720M $3.320M
YoY Change -32.64% 132.53% 395.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -310.0K 14.07M 620.0K
YoY Change -444.44% 2169.35% -513.33%
NET CHANGE
Cash From Operating Activities -6.790M -10.52M -10.68M
Cash From Investing Activities 4.830M 7.720M 3.320M
Cash From Financing Activities -310.0K 14.07M 620.0K
Net Change In Cash -2.270M 11.27M -6.740M
YoY Change -85.06% -267.21% -696.46%
FREE CASH FLOW
Cash From Operating Activities -$6.790M -$10.52M -$10.68M
Capital Expenditures -$520.0K -$420.0K -$1.320M
Free Cash Flow -$6.270M -$10.10M -$9.360M
YoY Change -72.12% 7.91% -1000.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44638819 shares
CY2013Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2451000
CY2013Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2355000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18138000
CY2014Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1580000
CY2014Q2 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
4300000
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44306000 shares
CY2014Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4117647 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44306000 shares
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2436000 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
2.26
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2014Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
3909000
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20714000
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
67403000
CY2014Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4929000
CY2014Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
456836000
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
29881000
CY2014Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
50161000
CY2014Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1392000
CY2014Q3 us-gaap Restructuring Reserve
RestructuringReserve
4323000
CY2014Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
91800000
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
50602000
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0
CY2014Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1324000
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2408000
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1615000
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
25161000
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3586000
CY2014Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
786000
CY2014Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3327000
CY2014Q3 us-gaap Deferred Revenue
DeferredRevenue
1009000
CY2014Q3 us-gaap Loss Contingency Accrual Carrying Value Noncurrent
LossContingencyAccrualCarryingValueNoncurrent
5000000
CY2014Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
9727000
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-406719000
CY2014Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11424000
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
44000
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
93045000
CY2014Q3 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
0
CY2014Q3 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
414000
CY2014Q3 us-gaap Liabilities
Liabilities
66944000
CY2014Q3 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
7000
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5097000
CY2014Q3 us-gaap Assets Current
AssetsCurrent
84776000
CY2014Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
5358000
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1527000
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
622000
CY2014Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
261000
CY2014Q3 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
0
CY2014Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
81000
CY2014Q3 us-gaap Assets
Assets
93045000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20163000
CY2014Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
3830000
CY2014Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
91900000
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27257000
CY2014Q3 us-gaap Inventory Net
InventoryNet
28139000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
562000
CY2014Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1347000
CY2014Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
5358000
CY2014Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
42520000
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4020000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
561000
CY2014Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
100000
CY2014Q3 us-gaap Treasury Stock Value
TreasuryStockValue
25000000
CY2014Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
24309000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
224000
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5778000
CY2014Q3 mifi Cash Equivalents And Marketable Securities Held At Bank
CashEquivalentsAndMarketableSecuritiesHeldAtBank
2600000
CY2014Q3 mifi Market Development Fund And Price Protection
MarketDevelopmentFundAndPriceProtection
2416000
CY2014Q3 mifi Intangible Assets Impaired Accumulated Impairment Loss
IntangibleAssetsImpairedAccumulatedImpairmentLoss
29749000
CY2014Q3 mifi Acquired Intangible Assets Accumulated Amortization
AcquiredIntangibleAssetsAccumulatedAmortization
13729000
CY2014Q3 mifi Availableforsale Securities Gross Unrealized Gain Loss Accumulated In Aoci
AvailableforsaleSecuritiesGrossUnrealizedGainLossAccumulatedInAoci
5000
CY2014Q3 mifi Available For Sale Securities Gross Unrealized Gain Accumulated In Investment
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestment
0
CY2014Q3 mifi Available For Sale Securities Gross Unrealized Loss Accumulated In Investment
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestment
0
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2329000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16044000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34097000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34097000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2436000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
610000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23271000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62334000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4248000
CY2013Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2566000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
441368000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24538000
CY2013Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
69916000
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1040000
CY2013Q4 us-gaap Restructuring Reserve
RestructuringReserve
881000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
54701000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5000
CY2013Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2244000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4828000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1848000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
44916000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2449000
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
4243000
CY2013Q4 us-gaap Deferred Revenue
DeferredRevenue
2999000
CY2013Q4 us-gaap Loss Contingency Accrual Carrying Value Noncurrent
LossContingencyAccrualCarryingValueNoncurrent
10000000
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-371491000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10752000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
34000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
111465000
CY2013Q4 us-gaap Liabilities
Liabilities
66549000
CY2013Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
4326000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
16612000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
95629000
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
22616000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2131000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
280000
CY2013Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3443000
CY2013Q4 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
2566000
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
81000
CY2013Q4 us-gaap Assets
Assets
111465000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2911000
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6923000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39985000
CY2013Q4 us-gaap Inventory Net
InventoryNet
27793000
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2019000
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
22621000
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
42520000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5662000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
100000
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
25000000
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
20870000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9901000
CY2013Q4 mifi Market Development Fund And Price Protection
MarketDevelopmentFundAndPriceProtection
3059000
CY2013Q4 mifi Intangible Assets Impaired Accumulated Impairment Loss
IntangibleAssetsImpairedAccumulatedImpairmentLoss
29749000
CY2013Q4 mifi Consideration For Litigation Settlement Paid By Companys Insurers
ConsiderationForLitigationSettlementPaidByCompanysInsurers
1700000
CY2013Q4 mifi Acquired Intangible Assets Accumulated Amortization
AcquiredIntangibleAssetsAccumulatedAmortization
12983000
CY2013Q4 mifi Available For Sale Securities Gross Unrealized Gain Accumulated In Investment
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestment
5000
CY2013Q4 mifi Available For Sale Securities Gross Unrealized Loss Accumulated In Investment
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestment
0
CY2014Q2 mifi Amount For Share Price Fluctuation Related To Litigation Settlement
AmountForSharePriceFluctuationRelatedToLitigationSettlement
725000
CY2014Q2 mifi Probable Relief On Additional Cash Payment
ProbableReliefOnAdditionalCashPayment
725000
CY2014Q2 mifi Asserted Claims Not Accrued In Financial
AssertedClaimsNotAccruedInFinancial
725000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33902000 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4182000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
us-gaap Interest Paid Net
InterestPaidNet
31000
us-gaap Revenues
Revenues
269718000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2169000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22131000
us-gaap Gross Profit
GrossProfit
56255000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
22238000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
59000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
10969000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-83000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
4086000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
109000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21793000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-21767000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5895000
us-gaap Net Income Loss
NetIncomeLoss
-22107000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8922000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5048000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-24000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
273000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19209000
us-gaap Inventory Write Down
InventoryWriteDown
3069000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1916000
us-gaap Share Based Compensation
ShareBasedCompensation
2848000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1005000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6774000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
13400000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2094000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16739000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
4445000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2832000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
4060000
us-gaap Cost Of Revenue
CostOfRevenue
213463000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39267000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
-515000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
422000
us-gaap Restructuring Charges
RestructuringCharges
2411000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2848000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
31731000
us-gaap Operating Expenses
OperatingExpenses
78048000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
340000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-85000
mifi Non Cash Income Tax Expense Benefit
NonCashIncomeTaxExpenseBenefit
-266000
mifi Building Rent Incentives To Fund Leasehold Improvements
BuildingRentIncentivesToFundLeaseholdImprovements
359000
mifi Non Cash Financing Activities Derivative Liabilities
NonCashFinancingActivitiesDerivativeLiabilities
0
mifi Non Cash Financing Activities Fair Value Adjustment Of Warrants
NonCashFinancingActivitiesFairValueAdjustmentOfWarrants
0
mifi Issuance Of Common Stock For Settlement Of Shareholder Litigation
IssuanceOfCommonStockForSettlementOfShareholderLitigation
0
mifi Acquisition Of Common Stock From Anti Dilutive Securities
AcquisitionOfCommonStockFromAntiDilutiveSecurities
5885100 shares
dei Trading Symbol
TradingSymbol
MIFI
dei Entity Registrant Name
EntityRegistrantName
NOVATEL WIRELESS INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001022652
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
Each share of Series C Preferred Stock is initially convertible into ten shares of common stock
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
62000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35568000 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9484000
us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.01 pure
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.99
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segments
us-gaap Standard Product Warranty Description
StandardProductWarrantyDescription
One to three years of warranty coverage for products following the date of purchase
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11309000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 8%; MARGIN-TOP: 18px"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Use of Estimates</i></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 8%"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent liabilities. Actual results could differ materially from these estimates. Significant estimates include allowance for doubtful accounts receivable, provision for excess and obsolete inventory, valuation of intangible and long-lived assets, fair value of warrant liability, litigation and restructuring related accruals, provision for warranty costs, income taxes, share-based compensation expense and best estimate of selling price in a multiple element arrangement.</font></p> </div>
us-gaap Interest Paid Net
InterestPaidNet
80000
us-gaap Revenues
Revenues
129884000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1300000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35233000
us-gaap Gross Profit
GrossProfit
24541000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1255000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
83000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
2566000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-118000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1078000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-28000
us-gaap Operating Income Loss
OperatingIncomeLoss
-30221000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
143000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-35155000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11600000
us-gaap Net Income Loss
NetIncomeLoss
-35228000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3379000
us-gaap Payments For Restructuring
PaymentsForRestructuring
2739000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1513000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-4790000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4788000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
14163000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12881000
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
12300000
us-gaap Share Based Compensation
ShareBasedCompensation
1616000
us-gaap Inventory Write Down
InventoryWriteDown
3033000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
11222000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
17252000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9816000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
187000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5889000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
0
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
15602000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5500000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1998000
us-gaap Cost Of Revenue
CostOfRevenue
105343000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24164000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
-375000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
421000
us-gaap Restructuring Charges
RestructuringCharges
7480000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1616000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
18513000
us-gaap Operating Expenses
OperatingExpenses
54762000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-88000
mifi Non Cash Income Tax Expense Benefit
NonCashIncomeTaxExpenseBenefit
0
mifi Income Tax Interest Benefit On Uncertain Tax Positions
IncomeTaxInterestBenefitOnUncertainTaxPositions
0
mifi Building Rent Incentives To Fund Leasehold Improvements
BuildingRentIncentivesToFundLeaseholdImprovements
0
mifi Internal Revenue Code Ownership Percentage Change
InternalRevenueCodeOwnershipPercentageChange
0.50 pure
mifi Uncertain Income Tax Position Unrecognized
UncertainIncomeTaxPositionUnrecognized
Less than a 50% likelihood
mifi Additions To Restructuring Reserve
AdditionsToRestructuringReserve
7479000
mifi Internal Revenue Code Ownership Percentage Change Description
InternalRevenueCodeOwnershipPercentageChangeDescription
Annual use of the Company's net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period.
mifi Restructuring Charges For Shared Based Compensation Acceleration For Termination Of Chief Executive Officer
RestructuringChargesForSharedBasedCompensationAccelerationForTerminationOfChiefExecutiveOfficer
1298000
mifi Non Cash Financing Activities Derivative Liabilities
NonCashFinancingActivitiesDerivativeLiabilities
4939000
mifi Non Cash Financing Activities Fair Value Adjustment Of Warrants
NonCashFinancingActivitiesFairValueAdjustmentOfWarrants
4788000
mifi Issuance Of Common Stock For Settlement Of Shareholder Litigation
IssuanceOfCommonStockForSettlementOfShareholderLitigation
5000000
mifi Acquisition Of Common Stock From Anti Dilutive Securities
AcquisitionOfCommonStockFromAntiDilutiveSecurities
5313009 shares
CY2013 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
62000
CY2013 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
5000000
CY2013 mifi Legal Settlements Promissory Notes Issued Amount
LegalSettlementsPromissoryNotesIssuedAmount
5000000
CY2013 mifi Legal Settlements Shares Issued Value
LegalSettlementsSharesIssuedValue
5000000
CY2013 mifi Loss Contingency Damages Paid Net Of Portion Paid By Companys Insurers
LossContingencyDamagesPaidNetOfPortionPaidByCompanysInsurers
4300000
CY2013Q3 us-gaap Revenues
Revenues
92673000
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34070000 shares
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5079000
CY2013Q3 us-gaap Gross Profit
GrossProfit
20383000
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
59000
CY2013Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
722000
CY2013Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
31000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4864000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4774000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-5093000
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000
CY2013Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5128000
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5129000
CY2013Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
818000
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
72290000
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12438000
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
141000
CY2013Q3 us-gaap Restructuring Charges
RestructuringCharges
2411000
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
959000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
25247000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
319000
CY2013Q3 mifi Acquisition Of Common Stock From Anti Dilutive Securities
AcquisitionOfCommonStockFromAntiDilutiveSecurities
5668752 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38167000 shares
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2014Q3 us-gaap Revenues
Revenues
44330000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8837000
CY2014Q3 us-gaap Gross Profit
GrossProfit
10486000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-61000
CY2014Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
317000
CY2014Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-63000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3896000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8808000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-8832000
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000
CY2014Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4788000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3381000
CY2014Q3 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
3200000
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2790000
CY2014Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
573000
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
33844000
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7006000
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
141000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
14382000
CY2014Q3 us-gaap Restructuring Charges
RestructuringCharges
1064000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
377000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000
CY2014Q3 mifi Income Tax Interest Benefit On Uncertain Tax Positions
IncomeTaxInterestBenefitOnUncertainTaxPositions
0
CY2014Q3 mifi Acquisition Of Common Stock From Anti Dilutive Securities
AcquisitionOfCommonStockFromAntiDilutiveSecurities
4761066 shares

Files In Submission

Name View Source Status
0001193125-14-403325-index-headers.html Edgar Link pending
0001193125-14-403325-index.html Edgar Link pending
0001193125-14-403325.txt Edgar Link pending
0001193125-14-403325-xbrl.zip Edgar Link pending
d798507d10q.htm Edgar Link pending
d798507dex311.htm Edgar Link pending
d798507dex312.htm Edgar Link pending
d798507dex321.htm Edgar Link pending
d798507dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mifi-20140930.xml Edgar Link completed
mifi-20140930.xsd Edgar Link pending
mifi-20140930_cal.xml Edgar Link unprocessable
mifi-20140930_def.xml Edgar Link unprocessable
mifi-20140930_lab.xml Edgar Link unprocessable
mifi-20140930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending